Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
J Neurosurg
; : 1-8, 2022 Nov 11.
Article
in En
| MEDLINE
| ID: mdl-36681988
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
J Neurosurg
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos